A surgery to treat obesity is the last resort after exploring all other options, specialist doctors told a symposium in the capital on Saturday. “The Bariatric and Metabolic Institute (BMI) at Shaikh…
Category: News
Biomarker Shows Potential For Early Diagnosis Of Lung Cancer
A collaboration between physicians and scientists at UNC Lineberger Comprehensive Cancer Center and the University of Texas M.D. Anderson Cancer Center has demonstrated that a biomarker called TCF21 may be used to…
New Look At Multitalented Protein Sheds Light On Mysteries Of HIV
New insights into the human immunodeficiency virus (HIV) infection process, which leads to acquired immunodeficiency syndrome (AIDS), may now be possible through a research method recently developed in part at the National…
Genetic Variations Linked With Common Childhood Obesity Revealed By Study
A new study uncovers multiple genetic variations associated with common childhood obesity. The research, published by Cell Press on October 14th in the American Journal of Human Genetics, is likely to guide…
New Study Highlights Need To Address Both The Overuse And Underuse Of Recommended Colorectal Cancer Screening Tests
Only one-fifth of primary care physicians in the US follow practice guidelines for colorectal cancer screening for all the tests they recommend, according to Dr. Robin Yabroff from the National Cancer Institute…
Individualized Care Necessary For Kidney Disease Patients
1. One-Size-Fits-All Blood Pressure Recommendations Won’t Suit All Dialysis Patients Age, Race, and Diabetes Status Affect Blood Pressure’s Link to Premature Death. Previous research indicates that mild to moderate hypertension may not…
FDA Approves H.P. Acthar® Gel For The Treatment Of Infantile Spasms
Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced the U.S. Food and Drug Administration (FDA) has approved Questcor’s supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of…
FDA Approves Botox To Treat Chronic Migraine
The U.S. Food and Drug Administration approved Botox injection (onabotulinumtoxinA) to prevent headaches in adult patients with chronic migraine. Chronic migraine is defined as having a history of migraine and experiencing a…
Right Food Effectively Protects Against Risk For Diabetes, Cardiovascular Disease And Cognitive Decline
For the first time researchers have found out what effect multiple, rather than just single, foods with anti-inflammatory effects have on healthy individuals. The results of a diet study show that bad…
Long-Term Data On Cimzia® (certolizumab Pegol) For Moderate To Severe Crohn’s Disease To Be Highlighted At ACG Meeting
Studies and analyses of the Crohn’s disease (CD) treatment Cimzia® (certolizumab pegol) will be exhibited at the 2010 Annual Scientific Meeting of the American College of Gastroenterology, taking place in San Antonio…
Low Beta Blocker Dose Can Put Patients At Risk For Subsequent Heart Attacks
For nearly 40 years a class of drugs known as beta blockers have been proven to increase patients’ survival prospects following a heart attack by decreasing the cardiac workload and oxygen demand…
Therapeutic Benefits Of Bariatric Surgery On Diabetes Translate Into Significant Economic Benefits
New data presented at Obesity 2010, the 28th annual scientific meeting of The Obesity Society, find that bariatric surgery is associated with reduced healthcare costs for diabetes patients who are morbidly obese….
Genetic Data Related To Sodium-Regulating Hormone May Help Explain Hypertension Risk
New research points to the existence of a gene on chromosome 5 that influences how much aldosterone is produced – which may be excessive in African-descended populations. “Aldosterone was very important to…
Powerful Mutation Tool Identifies New Cancer Genes
Researchers have developed a genetic tool in mice to speed the discovery of novel genes involved in cancer. The system – called PiggyBac – has already been used by the team to…
Teriflunomide Successfully Reduces Relapses And Is Well Tolerated In Multiple Sclerosis Patients
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced the results from the two year phase III TEMSO study of teriflunomide, a novel oral disease modifier investigated for the treatment of relapsing multiple sclerosis…